275 related articles for article (PubMed ID: 26349899)
1. Expression of G1/S-cyclins and cyclin-dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma.
Brasanac D; Stojkovic-Filipovic J; Bosic M; Tomanovic N; Manojlovic-Gacic E
J Cutan Pathol; 2016 Mar; 43(3):200-10. PubMed ID: 26349899
[TBL] [Abstract][Full Text] [Related]
2. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
3. Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin.
Bosic MM; Brasanac DC; Stojkovic-Filipovic JM; Zaletel IV; Gardner JM; Cirovic SL
Exp Mol Pathol; 2016 Jun; 100(3):378-85. PubMed ID: 27019369
[TBL] [Abstract][Full Text] [Related]
4. Expression of Minichromosome Maintenance Proteins in Actinic Keratosis and Squamous Cell Carcinoma.
Stojkovic-Filipovic J; Brasanac D; Bosic M; Boricic N; Lekic B
Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):165-172. PubMed ID: 27299186
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
6. Expression of gelatinases (MMP-2, MMP-9) and gelatinase activator (MMP-14) in actinic keratosis and in in situ and invasive squamous cell carcinoma.
Hernández-Pérez M; El-hajahmad M; Massaro J; Mahalingam M
Am J Dermatopathol; 2012 Oct; 34(7):723-8. PubMed ID: 22534634
[TBL] [Abstract][Full Text] [Related]
7. MART-1-labeled melanocyte density and distribution in actinic keratosis and squamous cell cancer in situ: Pagetoid melanocytes are a potential source of misdiagnosis as melanoma in situ.
Fix WC; Yun SJ; Groft MacFarlane CM; Jambusaria A; Elenitsas R; Chu E; Etzkorn JR; Sobanko JF; Shin TM; Miller CJ
J Cutan Pathol; 2018 Oct; 45(10):734-742. PubMed ID: 29943494
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis.
Xie Q; Wang H; Heilman ER; Walsh MG; Haseeb MA; Gupta R
Eur J Dermatol; 2014; 24(1):41-5. PubMed ID: 24413452
[TBL] [Abstract][Full Text] [Related]
9. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
10. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
12. Genomic Progression of Precancerous Actinic Keratosis to Squamous Cell Carcinoma.
Kim YS; Shin S; Jung SH; Park YM; Park GS; Lee SH; Chung YJ
J Invest Dermatol; 2022 Mar; 142(3 Pt A):528-538.e8. PubMed ID: 34480890
[TBL] [Abstract][Full Text] [Related]
13. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin.
Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K
Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338
[TBL] [Abstract][Full Text] [Related]
14. Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions.
Bito T; Ueda M; Ito A; Ichihashi M
J Cutan Pathol; 1997 May; 24(5):305-8. PubMed ID: 9194584
[TBL] [Abstract][Full Text] [Related]
15. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
[TBL] [Abstract][Full Text] [Related]
16. The expression of antimicrobial peptides is significantly altered in cutaneous squamous cell carcinoma and precursor lesions.
Scola N; Gambichler T; Saklaoui H; Bechara FG; Georgas D; Stücker M; Gläser R; Kreuter A
Br J Dermatol; 2012 Sep; 167(3):591-7. PubMed ID: 22709331
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous squamous cell carcinoma progression is associated with decreased GATA-3 immunohistochemical staining.
Solus JF; Hassan K; Lee SJ; Hsi AC; Rosman IS; Dehmeri S; Schaffer A
J Cutan Pathol; 2016 Apr; 43(4):347-53. PubMed ID: 26762870
[TBL] [Abstract][Full Text] [Related]
19. p16INK4a expression in actinic keratosis and Bowen's disease.
Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
[TBL] [Abstract][Full Text] [Related]
20. Epithelial expression of extracellular matrix metalloproteinase inducer/CD147 and matrix metalloproteinase-2 in neoplasms and precursor lesions derived from cutaneous squamous cells: An immunohistochemical study.
Ayva SK; Karabulut AA; Akatli AN; Atasoy P; Bozdogan O
Pathol Res Pract; 2013 Oct; 209(10):627-34. PubMed ID: 23948694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
